MetLife, Inc. (MET) Holdings Trimmed by Altavista Wealth Management Inc.

Altavista Wealth Management Inc. lessened its stake in shares of MetLife, Inc. (NYSE:MET) by 2.4% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 58,580 shares of the financial services provider’s stock after selling 1,436 shares during the quarter. MetLife comprises 1.6% of Altavista Wealth Management Inc.’s portfolio, making the stock its 24th largest holding. Altavista Wealth Management Inc.’s holdings in MetLife were worth $3,218,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently bought and sold shares of the company. Bronfman E.L. Rothschild L.P. grew its holdings in shares of MetLife by 0.7% during the second quarter. Bronfman E.L. Rothschild L.P. now owns 5,505 shares of the financial services provider’s stock worth $302,000 after purchasing an additional 38 shares in the last quarter. Forward Management LLC grew its holdings in shares of MetLife by 0.4% during the second quarter. Forward Management LLC now owns 9,661 shares of the financial services provider’s stock worth $531,000 after purchasing an additional 41 shares in the last quarter. Peoples Bank OH grew its holdings in shares of MetLife by 0.5% during the first quarter. Peoples Bank OH now owns 10,529 shares of the financial services provider’s stock worth $556,000 after purchasing an additional 50 shares in the last quarter. Aspen Investment Management Inc grew its holdings in shares of MetLife by 0.7% during the second quarter. Aspen Investment Management Inc now owns 7,178 shares of the financial services provider’s stock worth $394,000 after purchasing an additional 50 shares in the last quarter. Finally, Atria Investments LLC grew its holdings in shares of MetLife by 0.4% during the second quarter. Atria Investments LLC now owns 18,986 shares of the financial services provider’s stock worth $1,043,000 after purchasing an additional 72 shares in the last quarter. 74.25% of the stock is owned by institutional investors and hedge funds.

Shares of MetLife, Inc. (NYSE:MET) traded down 0.13% during trading on Thursday, hitting $52.78. The company had a trading volume of 1,073,067 shares. The company has a market capitalization of $56.10 billion, a P/E ratio of 620.94 and a beta of 1.47. The stock’s 50-day moving average price is $49.66 and its 200 day moving average price is $47.81. MetLife, Inc. has a 52 week low of $40.53 and a 52 week high of $53.30.

MetLife (NYSE:MET) last announced its earnings results on Wednesday, August 2nd. The financial services provider reported $1.30 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.28 by $0.02. MetLife had a return on equity of 8.51% and a net margin of 0.30%. The firm had revenue of $17.39 billion for the quarter, compared to the consensus estimate of $17.11 billion. During the same period in the previous year, the business earned $0.83 EPS. The firm’s revenue for the quarter was up 2.5% on a year-over-year basis. On average, equities research analysts forecast that MetLife, Inc. will post $4.62 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “MetLife, Inc. (MET) Holdings Trimmed by Altavista Wealth Management Inc.” was posted by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this report on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The original version of this report can be accessed at https://sportsperspectives.com/2017/10/12/metlife-inc-met-holdings-trimmed-by-altavista-wealth-management-inc.html.

Several research analysts have recently commented on MET shares. Royal Bank Of Canada reissued a “buy” rating and set a $62.00 price objective on shares of MetLife in a report on Wednesday, July 12th. Credit Suisse Group restated a “neutral” rating and issued a $53.00 target price (down previously from $64.00) on shares of MetLife in a research report on Monday, August 28th. Morgan Stanley boosted their target price on MetLife from $54.00 to $55.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 5th. Argus dropped their target price on MetLife from $60.00 to $55.00 and set a “buy” rating for the company in a research report on Wednesday, August 9th. Finally, ValuEngine upgraded MetLife from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, June 27th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and nine have issued a buy rating to the company. MetLife presently has a consensus rating of “Hold” and an average price target of $57.38.

About MetLife

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply